comparison of two drugs for better treatment of covid-19 related lung problems
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/12/029814
- Lead Sponsor
- PRATIMA SINGH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
All cases of covid 19 pneumonia who were diagnosed as COVID positive >=15 days back or antibody positive and continue to be breathless symptomatically, have SPo2 <=96%, CT-severity score >=10 and CORADS-4/5/6
Exclusion Criteria
-Patients having other interstitial lung diseases.
- Patient having CKD or creatinine clearance <30 and CLD with deranged LFT will be excluded.
-Not fulfilling the criteria for study
-Not giving consent for study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in CT-severity score <br/ ><br>Improvement in Arterial Blood Gas. <br/ ><br>Timepoint: 0, 6weeks, 12weeks
- Secondary Outcome Measures
Name Time Method Improvement in 6Minute Walk Distance.Timepoint: 6 weeks, 12 weeks